Business Context and Reporting Period
This Form 8-K Current Report was filed by NanoVibronix, Inc. (trading symbol: NAOV) on July 7, 2020. The registrant is an emerging growth company incorporated in Delaware. The report details two material events: a new distribution agreement and the resolution of a recent cybersecurity incident.
Key Financial Metrics
The filing does not provide standard financial metrics such as revenue, profit, cash flow, margins, or debt levels. The only specific financial figures disclosed relate to a cybersecurity incident:
- Total Fraudulent Transfers: Approximately $308,000.
- Recovered Funds: $78,000 (already deposited) and $230,000 (expected to be deposited).
- Net Financial Impact: The filing indicates the full amount of the fraudulent transfers has been or is expected to be recovered, implying no net loss to the company.
Material Changes
Distribution Agreement: Effective June 22, 2020, the Company entered into a two-year exclusive agreement with Ultra Pain Products, Inc. This agreement covers the distribution of the Company's proprietary PainShield devices and components through Durable Medical Equipment (DME) Distributors across the United States.
Cybersecurity Incident Resolution: The Company previously reported an incident where unauthorized parties used a spoofed email domain to divert vendor payments. As of this filing, the Company has recovered the full $308,000 in misdirected funds.
Outlook, Risks, and Management Commentary
Management Commentary: The CEO, Brian Murphy, signed the report confirming the new distribution partnership and the successful recovery of funds from the cybersecurity breach.
Risks and Contingencies: The filing highlights the risk of cybersecurity threats, specifically business email compromise. However, the immediate contingency regarding the $308,000 loss has been resolved with full recovery of funds.
Guidance: The filing does not contain updated financial guidance or forward-looking projections regarding revenue or earnings.
Investor Verification Checklist
- Verify the terms and exclusivity scope of the agreement with Ultra Pain Products, Inc. via the attached press release (Exhibit 99.1).
- Confirm the actual deposit of the remaining $230,000 recovered from the second vendor into the Company's accounts.
- Review the Company's cybersecurity protocols to assess the likelihood of future incidents.
- Note that the filing text does not provide updated revenue or profitability data; refer to the most recent 10-Q or 10-K for financial performance.